MBOAT7 and neurodevelopmental disorder: These findings suggest some potential therapeutic strategies for treating human neurodevelopmental disorders arising from MBOAT7 mutations, such as supplementation with arachidonic acid or arachidonic-acid-containing PI and pharmacological activation of PIPKIγ.